Skip to main content
. 2024 Dec 4;27(12):111437. doi: 10.1016/j.isci.2024.111437

Figure 6.

Figure 6

miR-532-3p promotes OXA/5-Fu resistance in vivo

(A–C) Tumor volumes and weights of mice bearing QBC939 cells (stably overexpressing miR-532-3p or control) 2 weeks following the first drug injection.

(D–F) Tumor volumes and weights of mice bearing FRH0201 cells (stably underexpressing miR-532-3p or control) after 2 weeks following the first drug injection. Data are represented as mean ± SD. n = 5, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, OXA oxaliplatin, 5-Fu 5-fluorouracil, NC negative control.